Evaluation of different partial AUCs as indirect measures of rate of drug absorption in comparative pharmacokinetic studies

European Journal of Pharmaceutical Sciences

Volumn 6, Issue 4, 1998, Pages 259-263

  Duquesnoy, C ^a   Lacey, L F ^b   Keene, O N ^b   Bye, A ^b  

^a Laboratoire Glaxo Wellcome   (France)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Absorption rate; Bioequivalence; Metrics; Partial area under the curve; Pharmacokinetics

Indexed keywords

GENERIC DRUG;

ACCURACY; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG ABSORPTION; DRUG FORMULATION; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; PHARMACOKINETICS; PRIORITY JOURNAL; SIMULATION; STATISTICAL ANALYSIS;

AREA UNDER CURVE; COMPUTER SIMULATION; INTESTINAL ABSORPTION; MODELS, STATISTICAL; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS; THERAPEUTIC EQUIVALENCY;

EID: 0032189211     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-0987(97)10023-9     Document Type: Article

References (18)

1. Bois, F.Y., Tozer, T.N., Hauck, W.W., Chen, M.-L., Patnaik, R., Williams, R.L., 1994. Bioequivalence: Performance of several measures of extent of absorption. Pharm. Res. 11 (5), 715-722.
2. Bois, F.Y., Tozer, T.N., Hauck, W.W., Chen, M.-L., Patnaik, R., Williams, R.L., 1994. Bioequivalence: Performance of several measures of rate of absorption. Pharm. Res. 11 (7), 966-974.
3. Cartwright, A.C., 1991. Barcelona Drug Information Association Workshop International consensus statement on bioavailability / bioequivalence testing requirements and standards. Drug Inf. J. 25, 473-482.
4. Chen, M.-L., 1992. An alternative approach for assessment of rate of absorption in bioequivalence studies. Pharm. Res. 9 (11), 1380-1385.
5. CPMP Guideline: Investigation of bioavailability and bioequivalence. Doc:III/54/89-EN.
6. Diletti, E., Hauschke, D., Steinijans, V.W., 1991. Sample size determination for bioequivalence assessment by means of confidence intervals. Int. J. Clin. Pharmacol. Ther. Toxicol. 29, 1-8.
7. max for absorption rates in investigations of bioequivalence. Int. J. Clin. Pharmacol. Ther. Toxicol. 29, 394-399.
8. Gibaldi, M., Perrier, D., 1982. Pharmacokinetics. Volume 15, Drugs and the Pharmaceutical Sciences (second ed.). Marcel Dekker, New York.
9. FDA Guidance, 1992. Statistical procedures for bioequivalence studies using a standard two-treatment crossover design. Office of Generic Drugs, FDA.
10. Hauschke, D., Steinijans, V.W., Diletti, E., 1990. A distribution-free procedure for the statistical analysis of bioequivalence studies. Int. J. Clin. Pharmacol. Ther. Toxicol. 28, 72-78.
11. Lacey, L.F., Keene, O.N., Duquesnoy, C., Bye, A., 1994. Evaluation of different indirect measures of rate of drug absorption in comparative pharmacokinetic studies. J. Pharm. Sci. 83 (2), 212-215.
12. Macheras, P., Symillides, M., Reppas, C., 1993. Estimation of absorption rate-constant in a one compartment model using the profile of the bioavailable dose eliminated as a function of multiples of half-life. J. Pharm. Sci. 82 (12), 1298-1300.
13. Macheras, P., Symillides, M., Reppas, C., 1994. The cut-off time point of the partial area method for assessment of rate of absorption in bioequivalence studies. Pharm. Res. 11 (6), 831-834.
14. Midha, K.K., Hubbard, J.W., Rawson, M., Gavalas, L., 1994. The application of partial areas in assessment of rate and extent of absorption in bioequivalence studies of conventional release products: experimental evidence. Eur. J. Pharm. Sci. 2 (5-6), 351-363.
15. Pabst, G., Jaeger, H., 1990. Review of methods and criteria for the evaluation of bioequivalence studies. Eur. J. Clin. Pharmacol. 38, 5-10.
16. FDA Proceedings, 1991. Proceedings of the Generic Drugs Advisory Committee Meeting, Food and Drug Administration, Centre for Drug Evaluation and Research, Office of Generic Drugs; C.A.S.E.T. Associates, Fairfax, Virginia, USA.
17. Rostami-Hodjegan, A., Jackson, P.R., Tucker, G.T., 1994. Sensitivity of indirect metrics for assessing rate in bioequivalence studies. Moving the goalposts or changing the game?. J. Pharm. Sci. 83 (11), 1554-1557.
18. Schuirmann, D.J., 1987. A comparison of the two one-sided test procedure and the power approach for assessing the equivalence of average bioavailability. J. Pharmacokinet. Biopharm. 15, 657-680.